## GL: Globe Life Inc. - XLF: Financial Services

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.3% in lower entry zone (4.0-10.0%), top quartile (80th pct) cross-sectional ranking. Short-term MRS_5 (0.3%) confirms momentum alignment. Outperforming sector by 2.1%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($137.22)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Cornerstone Management Inc. Sells 14,953 Shares of Globe Life Inc. $GL**
- Source: MarketBeat | 20251221T093219 | Somewhat-Bullish | Relevance: 100%
- Cornerstone Management Inc. significantly reduced its stake in Globe Life Inc. by selling 14,953 shares, representing a 63.1% cut. Concurrently, Globe Life's CEO Frank M. Svoboda also sold a portion of his holdings. Despite these sales, Globe Life recently beat quarterly EPS estimates and received largely bullish analyst ratings with a "Moderate Buy" consensus and an average price target of $164.89.

**2. Squarepoint Ops LLC Purchases 9,526 Shares of Globe Life Inc. $GL**
- Source: MarketBeat | 20251220T104904 | Somewhat-Bullish | Relevance: 98%
- Squarepoint Ops LLC significantly increased its stake in Globe Life Inc. by 223.5%, acquiring an additional 9,526 shares, bringing their total holdings to 13,789 shares valued at $1.71 million. This comes as CEO Frank M. Svoboda trimmed his position by over 20%, selling 9,379 shares for $1.32 million. Analysts maintain a largely positive outlook on Globe Life with an average "Moderate Buy" rating and a target price of $164.89, following strong Q3 EPS results and a declared quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-11 | TD Cowen | $199 | $182 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-11 | TD Cowen | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($3.74M) |
| Sells | 2 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 8 |

**Top Holders:**
- Vanguard Group Inc: 12.6% (-2.7%)
- Blackrock Inc.: 7.2% (-2.1%)
- Invesco Ltd.: 4.8% (-1.9%)
- State Street Corpora: 4.1% (-3.5%)
- Wellington Managemen: 3.5% (-29.0%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.68 elevated, pricing in significant growth expectations. Forward P/E 9.5x stretched relative to 3% growth. Quality metrics strong (ROE 22%, margin 19%). Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (1 raises, avg +9%). Insider buying signal ($3.7M), management confidence. Institutional flow bullish (2 buying vs 8 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $11.5B |
| Beta | 0.48 |
| 52W Range | $107.25 - $147.83 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.68 |
| Forward P/E | 9.5 |
| Current P/E | 9.8 |
| YoY Growth | 2.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 80th percentile. MRS_5 at 0.3% confirms short-term momentum alignment. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.79), confirming momentum. Elevated volume (1.4x 20MA), institutional activity likely. OFD pattern: +SUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.31% (CS: 81) | Strong |
| RSI_14 | 69.7 | Neutral |
| MACD Histogram | 0.79 | Bullish |
| vs SMA20 | 1.049x | Above |
| vs SMA50 | 1.060x | Above |
| vs SMA200 | 1.094x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $142.46
- **Stop Loss:** $137.22 (3.7% risk)
- **Target:** $150.32 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 171
- **Position Value:** $24,360.66
- **Portfolio %:** 24.36%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-04 (Est: $3.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $4.54 | $4.81 | +5.9% |
| 2025Q2 | $3.25 | $3.27 | +0.8% |
| 2025Q1 | $3.24 | $3.07 | -5.2% |
| 2024Q4 | $3.12 | $3.14 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*